Subject category:
Production and Operations Management
Published by:
Harvard Business Publishing
Version: 26 November 1991
Length: 5 pages
Data source: Published sources
Share a link:
https://casecent.re/p/46717
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
Monsanto has yet to receive FDA approval for BST, a growth hormone for cows. Anti-BST groups have successfully lobbied Wisconsin and Minnesota, major milk producing states, to ban milk from BST-injected cows; the FDA has charged Monsanto with improperly promoting BST before receiving approval and eventual consumer acceptance of BST generated produce is uncertain.
Locations:
Industries:
Size:
Fortune 500, USD9 billion revenues
Other setting(s):
1990-1991
Subject category:
Production and Operations Management
Published by:
Harvard Business Publishing
Length: 7 pages
Data source: Published sources
About
Abstract
Monsanto has yet to receive FDA approval for BST, a growth hormone for cows. Anti-BST groups have successfully lobbied Wisconsin and Minnesota, major milk producing states, to ban milk from BST-injected cows; the FDA has charged Monsanto with improperly promoting BST before receiving approval and eventual consumer acceptance of BST generated produce is uncertain.
Settings
Locations:
Industries:
Size:
Fortune 500, USD9 billion revenues
Other setting(s):
1990-1991
Related
Subject category:
Production and Operations Management
Published by:
Harvard Business Publishing
Length: 7 pages
Data source: Published sources